05B4 Wenger, David A - Jefferson Medical College - Thomas Jefferson University
David A. Wenger, PhD

David A. Wenger, PhD

Contact Dr. Wenger

1020 Locust Street
Room 394
Philadelphia, PA 19107

(215) 955-1666
(215) 955-9554 fax

Most Recent Peer-reviewed Publications

  1. Patient with unilateral white matter involvement does not have Krabbe disease
  2. Metachromatic leukodystrophy: A case of triplets with the late infantile variant and a systematic review of the literature
  3. Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy
  4. The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: Report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York
  5. Significant correction of pathology in brains of twitcher mice following injection of genetically modified mouse neural progenitor cells
  6. Newborn Screening for Krabbe Disease: the New York State Model
  7. Sphingomyelinase deficiency (Niemann-Pick disease) in a Hereford calf
  8. Brain proton magnetic resonance spectroscopy and neuromuscular pathology in a patient with GM1 gangliosidosis
  9. A single mutation in the GALC gene is responsible for the majority of late onset Krabbe disease patien 1329 ts in the Catania (Sicily, Italy) region.
  10. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease
  11. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: Evidence from a mouse model of Krabbe leukodystrophy
  12. Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice
  13. Insulin-like growth factor-1 provides protection against psychosine-induced apoptosis in cultured mouse oligodendrocyte progenitor cells using primarily the PI3K/Akt pathway
  14. Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease
  15. AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2
  16. Biochemical and pathological evaluation of long-lived mice with globoid cell leukodystrophy after bone marrow transplantation
  17. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease
  18. AAV-Mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy
  19. Clinical, biochemical, and molecular diagnosis of a free sialic acid storage disease patient of moderate severity
  20. Cord-Blood Transplants from Unrelated Donors in Patients with Hurler's Syndrome
0